 The investigators now propose a larger-scale randomized controlled trial to determine the effects of exercise on renal functions, cardiovascular fitness, inflammation, and oxidative stress in diabetic patients with CKD. This will be a 52-week randomized study based on the investigators pilot study design with some modifications. As opposed to the 6-week training period and 18-week home exercise period utilized in the pilot study, subjects randomized to exercise will undergo 12 weeks of intensive exercise training in the exercise laboratory followed by 40 weeks of supervised home exercise training total duration of study 1 year. Moreover, due to recent recommendations that resistance training be incorporated into exercise training regimens in type 2 diabetic patients, the investigators will incorporate resistance strength training in this proposal. The primary outcome variable will be change in proteinuria at 12 and 52 weeks. Secondary outcome variables will be change in albuminuria and estimated glomerular filtration rate eGFR at 12 and 52 weeks. In addition, the investigators will measure blood pressure BP, glycated hemoglobin, lipid profile, C-reactive protein CRP levels, body weight and composition, endothelial dysfunction by flow-mediated dilatation, and Quality of Life QoL evaluations. The Index of Coexistent Diseases ICED to measure comorbidities to determine if comorbid conditions had any influence on the outcomes of the study. The Center for Epidemiologic Studies Depression Scale CES-D will also be used to determine the influence of depression covariate on study outcomes and adherence with the study objectives. 